Evaluation of the sexual quality of life and sexual function of cervical cancer survivors after cancer treatment: a retrospective trial
Xiaotong Wu,Lingying Wu,Jinsong Han,Yumei Wu,Tingting Cao,Yunong Gao,Sha Wang,Shiyan Wang,Qing Liu,Hongxia Li,Na Yu,Haibo Wang,Yi Li,Zhiqi Wang,Xiuli Sun,Jianliu Wang
DOI: https://doi.org/10.1007/s00404-021-06005-x
2021-01-01
Archives of Gynecology and Obstetrics
Abstract:Objective The purpose of this study was to explore the factors influencing the sexual quality of life of patients with cervical cancer who underwent radical hysterectomy. Methods This multicenter retrospective cohort study was conducted from June 2013 to June 2018 at nine hospitals in China. In total, 204 women diagnosed with stage IA to stage IIB cervical cancer who underwent radical hysterectomy completed the questionnaire. Sexual function was measured with the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ). All analyses were performed with R version 3.4.3 statistical software packages. A two-sided significance level of 0.05 was used to evaluate the statistical significance. Results The mean sexual quality of life score was 37.21 ± 17.28, where a higher PISQ score indicates a better sexual quality of life, and we identified the factors associated with sexual dysfunction. The average follow-up time was 29.0 ± 16.0 months. In addition to radical hysterectomy, 182 (89.2%) patients underwent ovarian suspension, 93 (45.6%) underwent chemotherapy, and 74 (36.3%) underwent concurrent radiotherapy. The univariate analysis confirmed that age represents a protective factor for sexual function (odds ratio (OR) 6.0, 95% confidence interval (CI) 1.1–10.8, p = 0.017). The patients who underwent ovarian suspension were more likely to experience a good sexual quality of life (OR − 7.2, 95% CI [− 14.8, − 0.4], p = 0.035) compared to those who did not undergo ovarian suspension. A significant negative association was observed between radiotherapy and the behavioral-emotive, physical and partner-related domains of the PISQ (behavioral-emotive, OR − 1.5, 95% CI [− 2.6, − 0.4], p = 0.011; physical, OR − 0.9, 95% CI [− 1.5, − 0.3], p = 0.006; partner-related, OR − 0.7, 95% CI [− 1.3, 0.0], p = 0.043). Chemotherapy and radiotherapy were common risk factors for sexual dysfunction, and radiotherapy exerted a stronger effect than chemotherapy. Conclusions This study shows that the sexual function of cervical cancer patients tends to be related to age, radiotherapy, and chemotherapy. However, across these factors, patients with preserved ovaries tend to return to a satisfactory sexual quality of life after recovering from surgery.